Joseph B. Long

Richard A. Bauman and Joseph B. Long of the Division of Military Casualty Research, Department of Polytrauma and Resuscitation.
...
Pre-clinical trials at WRAIR by Drs. Bauman and Long have demonstrated that cyclosporin reduces brain damage caused by nerve agents and trauma.Neurohistological outcomes, spatial memory and learning rates have been improved in animal models when cyclosporin is used.

Richard A. Bauman and Joseph B. Long of the Walter Reed Army Institute of Research (WRAIR).

Richard A. Bauman and Joseph B. Long of the Division of Military Casualty Research, Department of Polytrauma and Resuscitation.
...
Pre-clinical trials at WRAIR by Drs. Bauman and Long have demonstrated that cyclosporin reduces brain damage caused by nerve agents and trauma. Neurohistological outcomes, spatial memory and learning rates have been improved in animal models when cyclosporin is used.

WRAIR scientists Richard Bauman, Ph.D. and Joseph Long, Ph.D. have already shown improved outcomes with Maas cyclosporin formulas in animal models of brain injury from head trauma and nerve agents.

Lead WRAIR scientists Richard A. Bauman Ph.D. and Joseph B. Long Ph.D. presented their research at the 2004 annual meeting of the Society for Neurotrauma in San Diego, California.
...
Research conducted by Drs. Bauman and Long, with support from Maas scientists Eskil Elmer, M.D., Ph.D. and Marcus Keep, M.D., demonstrated that brain function, memory, learning, and retention rates are dramatically improved in animal models when cyclosporin treats traumatic brain injury.
...
Drs. Bauman, Long and Debra Yourick, Ph.D., also of WRAIR, performed the nerve agent research with contributions by Drs.